This review (2022) makes the cases for using MDMA-assisted therapy (MDMA-AT) in the treatment of borderline personality disorder (BPD). The authors draw parallels between using MDMA-AT to treat disorders similar to BPD, such as PTSD, and provide considerations for designing future clinical trials.
- Published
- Journal
- Focus
- Authors
- Traynor, J. M., Roberts, D. E., Ross, S., Zeifman, R., Choi-Kain, L.